Connect with us

Technology

IBM RELEASES FIRST-QUARTER RESULTS

Published

on

Double-digit Software and Infrastructure revenue growth; Strong margin expansion and double-digit profit and free cash flow growth

ARMONK, N.Y., April 22, 2026 /PRNewswire/ — IBM (NYSE: IBM) today announced first-quarter 2026 earnings results.

“The first quarter was a strong start to the year with broad-based revenue growth across our segments. These results reflect the integrated value of our portfolio and the trust clients put in us to improve their operations. As clients scale use cases, AI continues to be a tailwind for our global business. IBM products and services are helping clients orchestrate, deploy and govern AI across hybrid environments,” said Arvind Krishna, IBM chairman, president and chief executive officer. “Given this strong start, we continue to expect more than 5 percent constant currency revenue growth and an increase of about $1 billion in year-over-year free cash flow in 2026.”

First-Quarter Highlights

Revenue
– Revenue of $15.9 billion, up 9 percent, up 6 percent at constant currency
– Software revenue up 11 percent, up 8 percent at constant currency
– Consulting revenue up 4 percent, up 1 percent at constant currency
– Infrastructure revenue up 15 percent, up 12 percent at constant currency
Profit
– Gross Profit Margin: GAAP: 56.2 percent, up 100 basis points; Operating (Non-GAAP):
   57.7 percent, up 110 basis points
– Pre-Tax Income Margin: GAAP: 8.7 percent, up 80 basis points; Operating (Non-GAAP):
  13.4 percent, up 140 basis points
Cash Flow
– Year to date, net cash from operating activities of $5.2 billion; free cash flow of $2.2 billion

 

FIRST-QUARTER 2026 INCOME STATEMENT SUMMARY

 
 

Revenue

 

Gross

Profit

 
 

Gross

Profit

Margin

 
 

Pre-tax

Income

 

Pre-tax

Income

Margin

 

Net

Income

 

Diluted

Earnings

Per Share

GAAP from

Continuing

Operations

$ 15.9 B

 
 

$   8.9 B

 
 

56.2

%

 

$   1.4 B

 
 

8.7

%

 

$   1.2 B

 
 

$   1.28

 

Year/Year

9

% (1)

 

11

%

 

1.0

Pts

 

20

%

 

0.8

Pts

 

15

%

 

14

%

Operating

(Non-GAAP)

 
 
 

$   9.2 B

 
 

57.7

%

 

$   2.1 B

 
 

13.4

%

 

$   1.8 B

 
 

$   1.91

 

Year/Year

 
 
 

12

%

 

1.1

Pts

 

23

%

 

1.4

Pts

 

20

%

 

19

%

(1)  6% at constant currency.

“Our solid revenue growth, portfolio mix and productivity initiatives drove double-digit profit and free cash flow growth in the quarter,” said James Kavanaugh, IBM senior vice president and chief financial officer. “The durability of our portfolio combined with our disciplined execution continues to give us the financial flexibility needed to both invest in our business and return value to shareholders through our dividend.”

Segment Results for First Quarter

Software — revenues of $7.1 billion, up 11 percent, up 8 percent at constant currency:
– Hybrid Cloud (Red Hat) up 13 percent, up 10 percent at constant currency
– Automation up 10 percent, up 7 percent at constant currency
– Data up 19 percent, up 16 percent at constant currency
– Transaction Processing up 6 percent, up 2 percent at constant currency

Consulting — revenues of $5.3 billion, up 4 percent, up 1 percent at constant currency:
– Strategy and Technology up 4 percent, up 1 percent at constant currency
– Intelligent Operations up 4 percent, up 1 percent at constant currency

Infrastructure — revenues of $3.3 billion, up 15 percent, up 12 percent at constant currency:
– Hybrid Infrastructure up 28 percent, up 25 percent at constant currency
      — IBM Z up 51 percent, up 48 percent at constant currency
      — Distributed Infrastructure up 17 percent, up 13 percent at constant currency
– Infrastructure Support down 2 percent, down 6 percent at constant currency

Financing — revenues of $0.2 billion, up 15 percent, up 10 percent at constant currency

Cash Flow and Balance Sheet

In the first quarter, the company generated net cash from operating activities of $5.2 billion, up $0.8 billion year to year. IBM’s free cash flow was $2.2 billion, up $0.3 billion year to year. The company returned $1.6 billion to shareholders in dividends in the first quarter and invested in the acquisition of Confluent.

IBM ended the first quarter with $11.8 billion of cash, restricted cash and marketable securities, down $2.6 billion from year-end 2025. Debt, including IBM Financing debt of $12.8 billion, totaled $66.4 billion, up $5.1 billion year to date.

Full-Year 2026 Expectations

Revenue: The company continues to expect full-year constant currency revenue growth of more than 5 percent. At current foreign exchange rates, currency is expected to be about a half-point to one-point tailwind to growth for the year
Free cash flow: The company continues to expect full-year free cash flow to increase by about $1 billion year-over-year

Dividend Declaration

The IBM board of directors declared an increase in the regular quarterly cash dividend to $1.69 per common share, payable June 10, 2026 to stockholders of record as of May 8, 2026.

This is the 31st year in a row that IBM has increased its quarterly cash dividend. IBM has paid consecutive quarterly dividends since 1916.

Forward-Looking and Cautionary Statements

Except for the historical information and discussions contained herein, statements contained in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on the company’s current assumptions regarding future business and financial performance. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, including, but not limited to, the following: a downturn in economic environment and client spending budgets; a failure of the company’s innovation initiatives; damage to the company’s reputation; risks from investing in growth opportunities; failure of the company’s intellectual property portfolio to prevent competitive offerings and the failure of the company to obtain necessary licenses; the company’s ability to successfully manage acquisitions, alliances and divestitures, including integration challenges, failure to achieve objectives, the assumption or retention of liabilities and higher debt levels; fluctuations in financial results; impact of local legal, economic, political, health and other conditions; the company’s failure to meet growth and productivity objectives; ineffective internal controls; the company’s use of accounting estimates; impairment of the company’s goodwill or amortizable intangible assets; the company’s ability to attract and retain key employees and its reliance on critical skills; impacts of relationships with critical suppliers; product and service quality issues; the development and use of AI, including the company’s increased AI solutions and use of AI technologies; impacts of business with government clients; reliance on third party distribution channels and ecosystems; cybersecurity and data protection considerations; adverse effects related to climate change and other environmental matters; tax matters; legal proceedings and investigatory risks; the company’s pension plans; currency fluctuations and customer financing risks; impact of changes in market liquidity conditions and customer credit risk on receivables; risk factors related to IBM securities; and other risks, uncertainties and factors discussed in the company’s Form 10-Qs, Form 10-K and in the company’s other filings with the U.S. Securities and Exchange Commission or in materials incorporated therein by reference.

Any forward-looking statement in this release speaks only as of the date on which it is made. Except as required by law, the company assumes no obligation to update or revise any forward-looking statements.

Presentation of Information in this Press Release

In an effort to provide investors with additional information regarding the company’s results as determined by generally accepted accounting principles (GAAP), the company has also disclosed in this press release the following non-GAAP information, which management believes provides useful information to investors:

adjusting for currency (i.e., at constant currency);
presenting operating (non-GAAP) earnings per share amounts and related income statement items;
free cash flow;
net cash from operating activities excluding IBM Financing receivables;
adjusted EBITDA;
adjusted EBITDA margin.

The rationale for management’s use of these non-GAAP measures is included in Exhibit 99.2 in the Form 8-K that includes this press release and is being submitted today to the SEC.

Conference Call and Webcast

IBM’s regular quarterly earnings conference call is scheduled to begin at 5:00 p.m. ET, today. The Webcast may be accessed via a link at https://www.ibm.com/investor/events/earnings-1q26. Presentation charts will be available shortly before the Webcast.

Financial Results Below (certain amounts may not add due to use of rounded numbers; percentages presented are calculated from the underlying whole-dollar amounts).

Contact:      IBM
                    Tim Davidson, 914-844-7847
                    tfdavids@us.ibm.com 
    
                    Erin McElwee, 347-920-6825
                    erin.mcelwee@ibm.com

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

COMPARATIVE FINANCIAL RESULTS

(Unaudited; $ in millions except per share amounts)

 
 

Three Months Ended
March 31,

 
 

2026

 
 

2025

 

REVENUE BY SEGMENT

 
 
 
 
 

Software

$        7,052

 
 

$        6,336

 

Consulting

5,272

 
 

5,068

 

Infrastructure

3,326

 
 

2,886

 

Financing

220

 
 

191

 

Other

48

 
 

61

 

TOTAL REVENUE

15,917

 
 

14,541

 
 
 
 
 
 
 

GROSS PROFIT

8,950

 
 

8,031

 
 
 
 
 
 
 

GROSS PROFIT MARGIN

 
 
 
 
 

Software

82.8

%

 

83.6

%

Consulting

27.5

%

 

27.3

%

Infrastructure

56.9

%

 

52.8

%

Financing

43.4

%

 

45.8

%

 
 
 
 
 
 

TOTAL GROSS PROFIT MARGIN

56.2

%

 

55.2

%

 
 
 
 
 
 

EXPENSE AND OTHER INCOME

 
 
 
 
 

SG&A

5,089

 
 

4,886

 

R&D

2,173

 
 

1,950

 

Intellectual property and custom development income

(172)

 
 

(253)

 

Other (income) and expense

(1)

 
 

(165)

 

Interest expense

473

 
 

455

 

TOTAL EXPENSE AND OTHER INCOME

7,562

 
 

6,873

 
 
 
 
 
 
 

INCOME FROM CONTINUING OPERATIONS

BEFORE INCOME TAXES

1,387

 
 

1,158

 

Pre-tax margin

8.7

%

 

8.0

%

Provision for/(benefit from) income taxes

172

 
 

103

 

Effective tax rate

12.4

%

 

8.9

%

 
 
 
 
 
 

INCOME FROM CONTINUING OPERATIONS

$        1,216

 
 

$        1,054

 
 
 
 
 
 
 

DISCONTINUED OPERATIONS

 
 
 
 
 

Income from discontinued operations, net of taxes

0

 
 

1

 
 
 
 
 
 
 

NET INCOME

$        1,216

 
 

$        1,055

 
 
 
 
 
 
 

EARNINGS PER SHARE OF COMMON STOCK

 
 
 
 
 

Assuming dilution

 
 
 
 
 

Continuing operations

$         1.28

 
 

$         1.12

 

Discontinued operations

$         0.00

 
 

$         0.00

 

TOTAL

$         1.28

 
 

$         1.12

 
 
 
 
 
 
 

Basic

 
 
 
 
 

Continuing operations

$         1.30

 
 

$         1.14

 

Discontinued operations

$         0.00

 
 

$         0.00

 

TOTAL

$         1.30

 
 

$         1.14

 
 
 
 
 
 
 

WEIGHTED-AVERAGE NUMBER OF COMMON SHARES OUTSTANDING (M’s)

 
 
 
 
 

Assuming dilution

952.1

 
 

945.4

 

Basic

938.5

 
 

928.0

 

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEET

 (Unaudited)

 

($ in millions)

 

At March 31,
2026

 

At December 31,
2025

ASSETS:

 
 
 
 

Current assets:

 
 
 
 

Cash and cash equivalents

 

$            10,819

 

$              13,587

Restricted cash

 

45

 

54

Marketable securities

 

964

 

830

Notes and accounts receivable – trade, net

 

6,493

 

8,112

Short-term financing receivables

 
 
 
 

  Held for investment, net

 

5,767

 

7,344

  Held for sale

 

743

 

1,131

Other accounts receivable, net

 

1,242

 

1,052

Inventories

 

1,476

 

1,220

Deferred costs

 

1,157

 

1,084

Prepaid expenses and other current assets

 

3,209

 

2,530

Total current assets

 

31,914

 

36,944

 
 
 
 
 

Property, plant and equipment, net

 

5,781

 

5,899

Operating right-of-use assets, net

 

3,219

 

3,129

Long-term financing receivables, net

 

7,014

 

7,708

Prepaid pension assets

 

7,578

 

7,544

Deferred costs

 

831

 

825

Deferred taxes

 

8,552

 

8,610

Goodwill

 

74,709

 

67,717

Intangibles, net

 

14,624

 

11,391

Investments and sundry assets

 

2,009

 

2,112

Total assets

 

$          156,229

 

$            151,880

 
 
 
 
 

LIABILITIES:

 
 
 
 

Current Liabilities:

 
 
 
 

Taxes

 

$              2,053

 

$                2,347

Short-term debt

 

8,655

 

6,424

Accounts payable

 

4,039

 

4,756

Compensation and benefits

 

3,941

 

4,114

Deferred income

 

17,034

 

16,101

Operating lease liabilities

 

798

 

800

Other liabilities

 

3,582

 

4,116

Total current liabilities

 

40,101

 

38,658

 
 
 
 
 

Long-term debt

 

57,706

 

54,836

Retirement-related obligations

 

8,763

 

9,018

Deferred income

 

4,195

 

4,271

Operating lease liabilities

 

2,643

 

2,547

Other liabilities

 

9,767

 

9,810

Total liabilities

 

123,174

 

119,139

 
 
 
 
 

EQUITY:

 
 
 
 

IBM stockholders’ equity:

 
 
 
 

Common stock

 

63,936

 

63,318

Retained earnings

 

155,327

 

155,648

Treasury stock – at cost

 

(170,874)

 

(170,605)

Accumulated other comprehensive income/(loss)

 

(15,415)

 

(15,713)

Total IBM stockholders’ equity

 

32,974

 

32,648

 
 
 
 
 

Noncontrolling interests

 

81

 

93

Total equity

 

33,056

 

32,740

 
 
 
 
 

Total liabilities and equity

 

$          156,229

 

$            151,880

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

STATEMENT OF CASH FLOWS

(Unaudited)

 
 
 

Three Months Ended
March 31,

($ in millions)

 

2026

 

2025 (1)

Cash flows from operating activities:

 
 
 
 

Net income

 

$        1,216

 

$        1,055

Adjustments to reconcile net income to cash provided by operating activities:

 
 
 
 

Depreciation (2)

 

555

 

536

Amortization of capitalized software and acquired intangible assets

 

719

 

641

Stock-based compensation

 

506

 

401

Net (gain)/loss on divestitures, asset sales and other

 

(11)

 

(22)

Changes in operating assets and liabilities, net of acquisitions/divestitures

 

2,185

 

1,759

Net cash provided by operating activities

 

5,169

 

4,370

 
 
 
 
 

Cash flows from investing activities:

 
 
 
 

Payments for property, plant and equipment

 

(232)

 

(244)

Proceeds from disposition of property, plant and equipment/other

 

8

 

74

Investment in software

 

(159)

 

(151)

Purchases of marketable securities and other investments

 

(1,612)

 

(6,486)

Proceeds from disposition of marketable securities and other investments

 

1,971

 

927

Acquisition of businesses, net of cash acquired

 

(10,465)

 

(7,098)

Divestiture of businesses, net of cash transferred

 

1

 

(1)

Net cash provided by/(used in) investing activities

 

(10,489)

 

(12,979)

 
 
 
 
 

Cash flows from financing activities:

 
 
 
 

Proceeds from new debt

 

7,437

 

8,378

Payments to settle debt

 

(2,928)

 

(1,257)

Short-term borrowings/(repayments) less than 90 days – net

 

0

 

(29)

Common stock repurchases for tax withholdings

 

(350)

 

(284)

Proceeds from issuance of shares

 

178

 

216

Financing – other

 

(42)

 

(32)

Cash dividends paid

 

(1,576)

 

(1,549)

Net cash provided by/(used in) financing activities

 

2,719

 

5,443

 
 
 
 
 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

(177)

 

167

Net change in cash, cash equivalents and restricted cash

 

(2,777)

 

(2,999)

 
 
 
 
 

Cash, cash equivalents and restricted cash at the beginning of the period

 

13,640

 

14,160

Cash, cash equivalents and restricted cash at the end of the period

 

$       10,864

 

$       11,161

____________________

(1) Reclassified to align with the Consolidated Statement of Cash Flows presentation.

(2) Includes operating lease right-of-use assets amortization.

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

GAAP NET INCOME TO ADJUSTED EBITDA RECONCILIATION

(Unaudited)

 
 
 

Three Months Ended

March 31,

($ in billions)

 

2026

2025

Yr/Yr

Net income as reported (GAAP)

 

$    1.2

$    1.1

$    0.2

Less: income from discontinued operations, net of tax

 

0.0

0.0

0.0

Income from continuing operations

 

1.2

1.1

0.2

Provision for/(benefit from) income taxes from continuing ops.

 

0.2

0.1

0.1

Pre-tax income from continuing operations (GAAP)

 

1.4

1.2

0.2

Non-operating adjustments (before tax)

 
 
 
 

Acquisition-related charges (1)

 

0.6

0.6

0.1

Non-operating retirement-related costs/(income)

 

0.1

0.0

0.1

 
 
 
 
 

Operating (non-GAAP) pre-tax income from continuing ops.

 

2.1

1.7

0.4

 
 
 
 
 

Net interest expense

 

0.3

0.3

0.1

Depreciation/amortization of non-acquired intangible assets

 

0.7

0.7

0.0

Stock-based compensation

 

0.5

0.4

0.1

Workforce rebalancing charges

 

0.3

0.3

0.0

Corporate (gains) and charges (2)

 

0.0

0.0

0.0

 
 
 
 
 

Adjusted EBITDA

 

$    4.0

$    3.4

$    0.6

 
 
 
 
 

Revenue

 

$  15.9

$  14.5

9 %

GAAP net income margin

 

7.6 %

7.3 %

0.4pts

Adjusted EBITDA margin

 

25.0 %

23.4 %

1.7pts

____________________

(1) Primarily consists of amortization of acquired intangible assets.

(2) Primarily consists of unique corporate actions such as gains on divestitures and asset sales.

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

SEGMENT DATA

(Unaudited)

 
 
 

Three Months Ended March 31, 2026

 
 
 
 
 
 
 
 
 
 
 
 
 
 

($ in millions)

 

Software

 
 

Consulting

 
 

Infrastructure

 
 

Financing

 

Revenue

 

$          7,052

 
 

$          5,272

 
 

$             3,326

 
 

$            220

 

Segment profit

 

$          2,099

 
 

$             558

 
 

$                524

 
 

$            118

 

Segment profit margin

 

29.8

%

 

10.6

%

 

15.8

%

 

53.8

%

Change YTY revenue

 

11.3

%

 

4.0

%

 

15.3

%

 

14.8

%

Change YTY revenue – constant currency

 

7.9

%

 

0.9

%

 

11.7

%

 

10.2

%

 
 
 

Three Months Ended March 31, 2025

 
 
 
 
 
 
 
 
 
 
 
 
 
 

($ in millions)

 

 Software

 
 

Consulting

 
 

Infrastructure

 
 

Financing

 

Revenue

 

$          6,336

 
 

$          5,068

 
 

$             2,886

 
 

$            191

 

Segment profit

 

$          1,847

 
 

$             558

 
 

$                248

 
 

$              69

 

Segment profit margin

 

29.1

%

 

11.0

%

 

8.6

%

 

35.8

%

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

U.S. GAAP TO OPERATING (Non-GAAP) RESULTS RECONCILIATION

(Unaudited; $ in millions except per share amounts)

 
 

Three Months Ended March 31, 2026

 
 

Continuing Operations

 
 

GAAP

 
 

Acquisition-

Related

Adjustments (1)

 
 

Retirement-

Related

Adjustments (2)

 
 

Tax

Reform

Impacts

 
 

Operating

(Non-GAAP)

 

Gross profit

$  8,950

 
 

$                  237

 
 

$                     —

 
 

$          —

 
 

$          9,187

 

Gross profit margin

56.2

%

 

1.5

pts

 

pts

 

pts

 

57.7

%

SG&A

$  5,089

 
 

$                 (408)

 
 

$                     —

 
 

$          —

 
 

$          4,682

 

Other (income) & expense

(1)

 
 

 
 

(96)

 
 

 
 

(98)

 

Total expense & other (income)

7,562

 
 

(409)

 
 

(96)

 
 

 
 

7,057

 

Pre-tax income from continuing operations

1,387

 
 

646

 
 

96

 
 

 
 

2,129

 

Pre-tax income margin from continuing

operations

8.7

%

 

4.1

pts

 

0.6

pts

 

pts

 

13.4

%

Provision for/(benefit from) income taxes (3)

$     172

 
 

$                  137

 
 

$                      3

 
 

$           (4)

 
 

$             308

 

Effective tax rate

12.4

%

 

2.7

pts

 

(0.4)

pts

 

(0.2)

pts

 

14.5

%

Income from continuing operations

$  1,216

 
 

$                  508

 
 

$                    94

 
 

$            4

 
 

$          1,821

 

Income margin from continuing operations

7.6

%

 

3.2

pts

 

0.6

pts

 

0.0

pts

 

11.4

%

Diluted earnings per share: continuing

operations

$    1.28

 
 

$                 0.53

 
 

$                 0.10

 
 

$       0.00

 
 

$            1.91

 
 
 

Three Months Ended March 31, 2025

 
 

Continuing Operations

 
 

GAAP

 
 

Acquisition-

Related

Adjustments (1)

 
 

Retirement-

Related

Adjustments (2)

 
 

Tax

Reform

Impacts

 
 

Operating

(Non-GAAP)

 

Gross profit

$  8,031

 
 

$                  201

 
 

$                     —

 
 

$          —

 
 

$          8,232

 

Gross profit margin

55.2

%

 

1.4

pts

 

pts

 

pts

 

56.6

%

SG&A

$  4,886

 
 

$                 (353)

 
 

$                     —

 
 

$          —

 
 

$          4,533

 

Other (income) & expense

(165)

 
 

 
 

(23)

 
 

 
 

(187)

 

Total expense & other (income)

6,873

 
 

(357)

 
 

(23)

 
 

 
 

6,494

 

Pre-tax income from continuing operations

1,158

 
 

557

 
 

23

 
 

 
 

1,738

 

Pre-tax income margin from continuing

operations

8.0

%

 

3.8

pts

 

0.2

pts

 

pts

 

12.0

%

Provision for/(benefit from) income taxes (3)

$     103

 
 

$                  128

 
 

$                   (12)

 
 

$            2

 
 

$             221

 

Effective tax rate

8.9

%

 

4.5

pts

 

(0.8)

pts

 

0.1

pts

 

12.7

%

Income from continuing operations

$  1,054

 
 

$                  429

 
 

$                    35

 
 

$           (2)

 
 

$          1,517

 

Income margin from continuing operations

7.3

%

 

3.0

pts

 

0.2

pts

 

0.0

pts

 

10.4

%

Diluted earnings per share: continuing

operations

$    1.12

 
 

$                 0.45

 
 

$                 0.04

 
 

$       0.00

 
 

$            1.60

 

____________________

(1) Includes amortization of acquired intangible assets, in-process R&D, transaction costs, applicable retention, restructuring and related expenses, 
      tax charges related to acquisition integration and pre-closing charges, such as financing costs.

(2) Includes amortization of prior service costs, interest cost, expected return on plan assets, amortized actuarial gains/losses, the impacts of any plan 
      curtailments/settlements and pension insolvency costs and other costs.

(3) The tax impact on operating (non-GAAP) pre-tax income from continuing operations is calculated under the same accounting principles applied to 
      the GAAP pre-tax income.

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

GAAP OPERATING CASH FLOW TO FREE CASH FLOW RECONCILIATION

(Unaudited)

 
 
 

Three Months Ended
March 31,

($ in millions)

 

2026

 

2025

Net cash provided by operating activities per GAAP

 

$     5,169

 

$     4,370

 
 
 
 
 

Less: change in IBM Financing receivables

 

2,565

 

2,087

 
 
 
 
 

Net cash from operating activities excl. IBM Financing receivables

 

2,604

 

2,283

 
 
 
 
 

Capital expenditures, net

 

(384)

 

(321)

 
 
 
 
 

Free cash flow

 

$     2,220

 

$     1,962

 

INTERNATIONAL BUSINESS MACHINES CORPORATION

GAAP OPERATING CASH FLOW TO ADJUSTED EBITDA RECONCILIATION

(Unaudited)

 
 
 

Three Months Ended
March 31,

($ in billions)

 

2026

 

2025

Net cash provided by operating activities

 

$      5.2

 

$      4.4

 
 
 
 
 

Add:

 
 
 
 

Net interest expense

 

0.3

 

0.3

Provision for/(benefit from) income taxes from continuing operations

 

0.2

 

0.1

 
 
 
 
 

Less change in:

 
 
 
 

Financing receivables

 

2.6

 

2.1

Net (gain)/loss on divestitures, assets sales and other (1)

 

0.0

 

0.0

Other assets and liabilities/other, net (1,2)

 

(0.9)

 

(0.7)

 
 
 
 
 

Adjusted EBITDA

 

$      4.0

 

$      3.4

 
 
 
 
 

Revenue

 

$    15.9

 

$    14.5

Net cash provided by operating activities margin

 

32.5 %

 

30.1 %

Adjusted EBITDA margin

 

25.0 %

 

23.4 %

____________________

(1) Reclassified to align with the presentation of similar line items in the Statement of Cash Flows.

(2) Mainly consists of Changes in operating assets and liabilities, net of acquisitions/divestitures in the Statement of Cash Flows chart,

      workforce rebalancing charges, non-operating impacts, and corporate (gains) and charges, less the change in Financing receivables.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ibm-releases-first-quarter-results-302750827.html

SOURCE IBM

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

on

By

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Continue Reading

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

on

By

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Continue Reading

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

on

By

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system,  helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said  Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company

Continue Reading

Trending